Exact Sciences: Kim Popovits

Exact Sciences' board of directors has expanded from nine to ten members with the appointment of Kim Popovits as a class I member with a term ending at the company's 2025 annual meeting of shareholders. Popovits holds 40 years of experience in the healthcare industry, serving in various leadership roles at Genomic Health, Genentech, and American Critical Care. She served as president and CEO of Genomic Health from 2009 until it was acquired by Exact in 2019. Prior to that she was Genomic Health's chief operating officer.

Popovits has served on the board of directors of Kiniksa Pharmaceuticals, 10x Genomics, and Talis Biomedical, where she was also interim CEO from August 2021 to November 2021. She holds a BA in business from Michigan State University.